chr1-65389615-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001256864.2(DNAJC6):c.1456C>T(p.Leu486Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00204 in 1,614,060 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 28 hom. )
Consequence
DNAJC6
NM_001256864.2 missense
NM_001256864.2 missense
Scores
13
5
Clinical Significance
Conservation
PhyloP100: 3.69
Genes affected
DNAJC6 (HGNC:15469): (DnaJ heat shock protein family (Hsp40) member C6) DNAJC6 belongs to the evolutionarily conserved DNAJ/HSP40 family of proteins, which regulate molecular chaperone activity by stimulating ATPase activity. DNAJ proteins may have up to 3 distinct domains: a conserved 70-amino acid J domain, usually at the N terminus, a glycine/phenylalanine (G/F)-rich region, and a cysteine-rich domain containing 4 motifs resembling a zinc finger domain (Ohtsuka and Hata, 2000 [PubMed 11147971]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0070246756).
BP6
Variant 1-65389615-C-T is Benign according to our data. Variant chr1-65389615-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 445731.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-65389615-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0107 (1637/152280) while in subpopulation AFR AF = 0.0381 (1581/41536). AF 95% confidence interval is 0.0365. There are 22 homozygotes in GnomAd4. There are 754 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJC6 | NM_001256864.2 | c.1456C>T | p.Leu486Phe | missense_variant | Exon 11 of 19 | ENST00000371069.5 | NP_001243793.1 | |
DNAJC6 | NM_014787.4 | c.1285C>T | p.Leu429Phe | missense_variant | Exon 11 of 19 | NP_055602.1 | ||
DNAJC6 | NM_001256865.2 | c.1246C>T | p.Leu416Phe | missense_variant | Exon 12 of 20 | NP_001243794.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJC6 | ENST00000371069.5 | c.1456C>T | p.Leu486Phe | missense_variant | Exon 11 of 19 | 1 | NM_001256864.2 | ENSP00000360108.4 | ||
DNAJC6 | ENST00000395325.7 | c.1285C>T | p.Leu429Phe | missense_variant | Exon 11 of 19 | 1 | ENSP00000378735.3 | |||
DNAJC6 | ENST00000263441.11 | c.1246C>T | p.Leu416Phe | missense_variant | Exon 12 of 20 | 2 | ENSP00000263441.7 | |||
DNAJC6 | ENST00000494710.6 | c.1378C>T | p.Leu460Phe | missense_variant | Exon 11 of 12 | 5 | ENSP00000473821.1 |
Frequencies
GnomAD3 genomes AF: 0.0107 AC: 1635AN: 152162Hom.: 22 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1635
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00276 AC: 693AN: 251382 AF XY: 0.00208 show subpopulations
GnomAD2 exomes
AF:
AC:
693
AN:
251382
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00113 AC: 1651AN: 1461780Hom.: 28 Cov.: 31 AF XY: 0.000938 AC XY: 682AN XY: 727190 show subpopulations
GnomAD4 exome
AF:
AC:
1651
AN:
1461780
Hom.:
Cov.:
31
AF XY:
AC XY:
682
AN XY:
727190
Gnomad4 AFR exome
AF:
AC:
1391
AN:
33472
Gnomad4 AMR exome
AF:
AC:
62
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26134
Gnomad4 EAS exome
AF:
AC:
0
AN:
39698
Gnomad4 SAS exome
AF:
AC:
18
AN:
86256
Gnomad4 FIN exome
AF:
AC:
0
AN:
53414
Gnomad4 NFE exome
AF:
AC:
26
AN:
1111924
Gnomad4 Remaining exome
AF:
AC:
148
AN:
60392
Heterozygous variant carriers
0
81
162
244
325
406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0107 AC: 1637AN: 152280Hom.: 22 Cov.: 32 AF XY: 0.0101 AC XY: 754AN XY: 74470 show subpopulations
GnomAD4 genome
AF:
AC:
1637
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
754
AN XY:
74470
Gnomad4 AFR
AF:
AC:
0.0380634
AN:
0.0380634
Gnomad4 AMR
AF:
AC:
0.00248398
AN:
0.00248398
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00041425
AN:
0.00041425
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000588028
AN:
0.0000588028
Gnomad4 OTH
AF:
AC:
0.00568182
AN:
0.00568182
Heterozygous variant carriers
0
78
156
234
312
390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
139
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
433
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Apr 28, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 27, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Juvenile onset Parkinson disease 19A Benign:3
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 24, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
MetaRNN
Benign
T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;.;M;.
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;D;D
REVEL
Uncertain
Sift
Uncertain
.;D;D;D
Sift4G
Uncertain
D;T;T;T
Polyphen
0.97, 1.0
.;.;D;D
Vest4
0.37, 0.35
MVP
MPC
0.35
ClinPred
T
GERP RS
Varity_R
gMVP
Mutation Taster
=92/8
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at